Latest news
Loading news…
Tilos Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Lexington, Massachusetts, United States Founded 2016 11-50 employees For Profit
Tilos Therapeutics is a product-focused company that creates anti-LAP antibodies for cancer treatment.
Tilos Therapeutics was acquired by Merck in 2019.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
Company Info
- Founded
- 2016
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 2
- HQ
- Lexington, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Diversity spotlight
- Women Founded; Women Led
- Exit date
- Jun 10, 2019
- Closed
- Jun 10, 2019
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.6
- Trend (90d)
- 4.7
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Tilos Therapeutics
Loading news…
FAQs about Tilos Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.